Ischemia-reperfusion injury (I/R) represents inflammatory injury to the endothelium and underlying parenchymal tissues following reperfusion of hypoxic tissues. This general syndrome is responsible for both acute and chronic injury to various tissues including the myocardium, central nervous system, hind limb andintestine. Studies in rodent models implicate the complement system as a major mediator of injury (1-3). Serum natural IgM is also critical in the induction of injury in two distinct tissues for activation of complement (3, 4). A universal mechanism that would explain these observations is that the hypoxic endothelium expresses neoantigens that specifically bind natural IgM leading to activation of the classical pathway of complement and the inflammatory response. This project will test this hypothesis in three inter-related specific aims.
The first aim will test our hypothesis that natural IgM mediates local I/R injury and that a major source is CD11b+ peritoneal B-1 cells.
This aim will include identification of B-1 cell hybridomas that secrete IgM that induce I/R injury in vivo. One hybridoma clone (CM22) expressing specific antibody has been identified and it will be further characterized in the second aim. We will uncouple IgM binding to ischemic tissues and activation of complement pathway using various genetic approaches. In the final aim, we will examine the development and regulation of B cell subsets that express ischemia-specific anti-self-antibody. The proposed study is important as it will not only provide important reagents and murine models for furthering our understanding of the etiology of ischemia reperfusion injury but hopefully lead to the identification of a therapeutic approach to intervene in this major disorder of humans.
|Sadeghipour, Hamed; Torabi, Radbeh; Gottschall, James et al. (2017) Blockade of IgM-Mediated Inflammation Alters Wound Progression in a Swine Model of Partial-Thickness Burn. J Burn Care Res 38:148-160|
|Sheu, Eric G; Wakatsuki, Kohei; Oakes, Sean et al. (2016) Prevention of intestinal ischemia-reperfusion injury in humanized mice. Surgery 160:436-42|
|Bankova, L G; Dwyer, D F; Liu, A Y et al. (2015) Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice. Mucosal Immunol 8:596-606|
|Dwyer, Daniel F; Woodruff, Matthew C; Carroll, Michael C et al. (2014) B cells regulate CD4+ T cell responses to papain following B cell receptor-independent papain uptake. J Immunol 193:529-39|
|Bankova, Lora G; Lezcano, Cecilia; Pejler, Gunnar et al. (2014) Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. J Immunol 192:2812-20|
|Houde, Martin; Jamain, Marc-David; Labonte, Julie et al. (2013) Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1. J Pharmacol Exp Ther 346:31-7|
|Gurish, Michael F; Austen, K Frank (2012) Developmental origin and functional specialization of mast cell subsets. Immunity 37:25-33|
|Younan, George J; Heit, Yvonne I; Dastouri, Pouya et al. (2011) Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast Reconstr Surg 128:649e-58e|
|Younan, George; Suber, Freeman; Xing, Wei et al. (2010) The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. J Immunol 185:7681-90|
|Afnan, Jalil; Ahmadi-Yazdi, Cyrus; Sheu, Eric G et al. (2010) Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species. Am J Physiol Regul Integr Comp Physiol 298:R1675-81|
Showing the most recent 10 out of 34 publications